AHCO

In the past six months, AdaptHealth's stock was significantly impacted by a Q2 2026 earnings miss and a drastic cut to its full-year fiscal 2026 financial guidance in August 2026, leading to a 39.8% stock decline. In July 2026, the company agreed to sell its Diabetes Health business for $235.0 million to focus on its core segments. Harriss Currie was appointed as the new Chief Financial Officer in September 2026. The company also experienced significant margin compression due to ramp-up costs from a major West Coast capitated contract and a manufacturer price increase. AdaptHealth participated in several investor conferences, including the Jefferies Healthcare Services and Technology Conference and the Baird 2026 Global Healthcare Conference in September 2026.